Add Company
Join Now

Meditope Biosciences Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Meditope Biosciences's estimated annual revenue is currently $1.1M per year.(i)
  • Meditope Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Meditope Biosciences has 7 Employees.(i)
  • Meditope Biosciences grew their employee count by 0% last year.

Meditope Biosciences's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
EVP Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Meditope Biosciences?

Meditope Biosciences, Inc. is in possession of a revolutionary antibody platform technology called “SnAP” (Site-specific, novel, Antibody Platform), which can turn antibodies into a LEGO-like system. The power, elegance, and simplicity of SnAP allows for a broad range of molecules – toxins, proteins, radiolabels, other antibodies – to be ‘snapped’ on or off an antibody with predictability, precision and control. Meditope is using this technology to develop a preclinical pipeline of compelling cancer drugs including two new immuno-oncology product for prostate and bladder cancers.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M70%N/A
#2
$0.5M7-36%N/A
#3
$0.5M717%N/A
#4
$0.1M70%$2.8M
#5
$0.1M70%$4M